Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Return on Equity (2023 - 2025)

Cannabis Bioscience International Holdings' Return on Equity history spans 3 years, with the latest figure at 0.35% for Q4 2025.

  • For Q4 2025, Return on Equity fell 14.0% year-over-year to 0.35%; the TTM value through Nov 2025 reached 0.35%, down 14.0%, while the annual FY2025 figure was 0.38%, 39.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.35% at Cannabis Bioscience International Holdings, up from 0.34% in the prior quarter.
  • Across five years, Return on Equity topped out at 1.13% in Q3 2023 and bottomed at 0.34% in Q3 2025.
  • The 3-year median for Return on Equity is 0.52% (2024), against an average of 0.63%.
  • The largest annual shift saw Return on Equity plummeted -63bps in 2024 before it fell -14bps in 2025.
  • A 3-year view of Return on Equity shows it stood at 1.11% in 2023, then plummeted by -56bps to 0.49% in 2024, then fell by -28bps to 0.35% in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Return on Equity are 0.35% (Q4 2025), 0.34% (Q3 2025), and 0.35% (Q2 2025).